Editorial team,
and how we work.
AfterLoss Atlas is written by a small editorial team working from primary sources — ASPS statistics, peer-reviewed surgical journals, FDA labels, the ABPS registry. Here's how the content gets produced, how we source it, and what we refuse to do.
Who writes
AfterLoss Atlas is an iSimplifyMe publication, written and edited by a small in-house team. All authorship is published as “The AfterLoss Atlas Editorial Team.” Every page carries a dated “last reviewed” stamp in the footer, and any figure not yet individually verified against a primary source is flagged as such on the page itself.
How the process works
Every clinical claim — candidacy criteria, recovery timelines, complication rates, cost ranges, surgical-technique descriptions, drug-interaction guidance — is built from primary sources. A researcher gathers them: ASPS Plastic Surgery Statistics, peer-reviewed surgical journals (Plastic and Reconstructive Surgery, Aesthetic Surgery Journal), FDA drug labels, the ABPS public registry, CMS coverage criteria, and ASA perioperative guidance. AI assists with drafting and structuring the explainer copy and JSON-LD schema. A human editor then revises for voice, accuracy, and AEO hygiene, checks every claim against its source, and removes any AI hallucination or unsourced statement. Pages publish with inline citations and a dated “last reviewed” stamp; any figure not yet individually verified is flagged on the page.
What we don’t do
We don’t run advertorials. We don’t run a surgeon directory, and we don’t list, rank, endorse, or route individual surgeons — the site is editorial guidance on verifying a surgeon yourself. We don’t accept paid placement from compounding pharmacies, telehealth brands, manufacturer pharma, med-spa franchises, or device vendors. We don’t treat the “board-certified in cosmetic surgery” credential as equivalent to ABPS board certification (those are different and not equivalent credentials). We don’t use AI-generated patient photos. We don’t use deepfaked or stock before-and-afters. We don’t soften candidacy criteria to encourage consults — the honest answer is what the sources support, not what produces the most lead volume.
The post-Medvi standard
In February 2026 the FDA issued Warning Letter #721455 to Medvi, a telehealth company that built roughly $401M in revenue using 800-plus AI-generated fake doctor profiles and deepfaked patient before-and-after photos. AfterLoss Atlas exists in deliberate contrast to that pattern. Every claim on this site traces to a primary source and carries an inline citation; every page is checked by a human editor and dated; no imagery is AI-generated or deepfaked. Those are the practices designed to stand in opposition to the Medvi playbook. The trust standard is higher here than the typical health-content publisher because the alternative produced FDA enforcement.
Voice
Editorial. Authoritative without sterility. Patient-first, never marketing-first. Plain English on technical claims. Cite ASPS, NIH, peer-reviewed surgical journals inline. Atomic answers (40–60 words) lead every spoke. We treat the reader as an adult facing a real decision.
Corrections
Corrections policy lives on the methodology page. Email [email protected] with the page URL, the specific item, and your source. We log every correction in the page’s footer and update within 48 hours.